TL;DR: The Centers for Medicare & Medicaid Services modified NCD 210, governing home health nurse visits for heparin injection therapy, with an effective date of March 7, 2026. Here's what billing teams need to know before submitting claims under this coverage policy.
CMS heparin injection home health coverage policy under NCD 210 Medicare defines when skilled nursing visits are reimbursable for teaching or administering subcutaneous low-dose heparin to homebound patients. This policy covers two clinical populations: pregnant patients requiring anticoagulation, and patients who cannot tolerate warfarin and need treatment for deep venous thrombosis, pulmonary emboli, or other conditions requiring long-term anticoagulation. No specific CPT or HCPCS codes are listed in the NCD 210 policy document — your home health billing team will need to map visits to appropriate codes using your MAC's billing guidelines.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Home Health Nurses' Visits to Patients Requiring Heparin Injection |
| Policy Code | NCD 210 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Home Health Agencies, Skilled Nursing, OB/Obstetrics, Hematology, Vascular Medicine |
| Key Action | Audit active heparin home health cases for proper warfarin intolerance documentation and 6-month duration tracking before March 7, 2026 |
CMS Home Health Heparin Injection Coverage Criteria and Medical Necessity Requirements 2026
NCD 210 is the National Coverage Determination that governs Medicare coverage for home health nursing visits related to heparin injection therapy. The coverage policy is narrower than many billing teams assume. Two specific patient populations qualify — and documentation requirements differ between them.
Population 1: Pregnant patients requiring anticoagulation.
Heparin is now the accepted drug of choice for anticoagulation during pregnancy. A pregnant, homebound patient who needs anticoagulant therapy meets medical necessity for covered nursing visits. This group gets more flexibility on duration — more on that below.
Population 2: Non-pregnant patients who cannot tolerate warfarin.
Warfarin remains the usual drug of choice for deep venous thrombosis, pulmonary emboli, and other conditions requiring long-term anticoagulation. Heparin substitution is covered only when documentation justifies that the patient cannot tolerate warfarin. "Cannot tolerate" means demonstrated warfarin sensitivity — not patient preference, not convenience.
This is where claim denial risk is highest. If your documentation says "heparin preferred" instead of "warfarin sensitivity documented," expect a denial. The coverage policy is explicit: documented intolerance is the threshold, not clinical preference.
What the nursing visits cover:
CMS covers two types of visits under NCD 210:
| # | Covered Indication |
|---|---|
| 1 | Teaching visits — a nurse trains the patient or a caring person to self-administer subcutaneous heparin injections. CMS covers "several visits" for this purpose. The policy does not define a specific number, which creates documentation exposure. Justify each visit in the clinical record. |
| 2 | Administration visits — if the patient or caring person cannot administer the injection, a nurse gives the injection daily, seven days a week. These visits are reimbursable for up to six months. |
The homebound requirement applies to both populations. The patient must meet Medicare's homebound criteria. This isn't unique to NCD 210, but it's a common documentation gap. Confirm homebound status is documented and current before billing visits.
Prior authorization is not explicitly mentioned in NCD 210 itself. However, your Medicare Administrative Contractor may have local coverage determination policies that layer additional requirements on top of this NCD. Check with your MAC before assuming NCD 210 is your only compliance target.
CMS Heparin Home Health Coverage Criteria and Medical Necessity: Duration Limits and Extensions
The six-month duration limit is the most operationally significant part of this coverage policy. Get this wrong and you're billing non-covered visits.
For non-pregnant patients: Administration visits are covered for up to six months. After six months, coverage continues only if the prescribing physician justifies and documents the need for extended treatment. That documentation must be in the record before you bill. If it isn't there at the time of the visit, the claim will not hold up to audit.
For pregnant patients: The six-month cap does not apply the same way. If a pregnant patient meets the homebound criteria and ongoing anticoagulation is reasonable and necessary, visits beyond six months are reimbursable. Documentation of medical necessity beyond six months is not required for pregnant patients — the pregnancy itself, combined with homebound status and the anticoagulation order, is sufficient.
This distinction matters for your billing workflow. Pregnant patients and non-pregnant patients need different tracking logic in your system. If you're managing both populations under the same duration-tracking rule, you're likely over-denying claims for pregnant patients or under-documenting for non-pregnant ones.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Pregnant homebound patient requiring anticoagulation therapy | Covered | No specific codes listed in NCD 210 | Visits covered beyond 6 months if reasonable and necessary; no extended-duration documentation required |
| Deep venous thrombosis — patient cannot tolerate warfarin | Covered | No specific codes listed in NCD 210 | Documented warfarin sensitivity required; admin visits covered up to 6 months; physician must justify extension |
| Pulmonary emboli — patient cannot tolerate warfarin | Covered | No specific codes listed in NCD 210 | Same documentation and duration rules as DVT indication |
| Other conditions requiring long-term anticoagulation — patient cannot tolerate warfarin | Covered | No specific codes listed in NCD 210 | Physician documentation of warfarin intolerance must be in the record |
| Teaching visits (patient or caring person learning to self-administer) | Covered | No specific codes listed in NCD 210 | "Several visits" covered; no defined limit in NCD — document clinical necessity for each visit |
| Patient/caring person unable to self-administer — daily nursing visits | Covered up to 6 months (non-pregnant); beyond 6 months with physician justification | No specific codes listed in NCD 210 | Seven-days-a-week visit frequency is covered when medically necessary |
| Heparin for anticoagulation when warfarin is the clinical preference but tolerated | Not Covered | — | Warfarin remains drug of choice; heparin only substituted when intolerance is documented |
CMS Heparin Injection Home Health Billing Guidelines and Action Items 2026
The modification to NCD 210 is effective March 7, 2026. These are the actions your billing and clinical documentation teams need to take before that date.
| # | Action Item |
|---|---|
| 1 | Audit every active heparin home health case in your system now. Pull all current claims and open episodes involving subcutaneous heparin injections for homebound patients. Confirm each case falls into one of the two covered populations: documented warfarin intolerance, or pregnancy with anticoagulation need. |
| 2 | Verify warfarin intolerance documentation is explicit and dated. "Warfarin sensitivity" or "demonstrated warfarin intolerance" must appear in the physician's order or clinical notes. A note that says "heparin ordered" without a documented reason for not using warfarin is not sufficient. Flag these charts for physician addendum before March 7, 2026. |
| 3 | Set up separate duration-tracking for pregnant vs. non-pregnant patients. Non-pregnant patients hit the six-month coverage wall — and need physician-documented justification before you bill beyond it. Pregnant patients do not face the same documentation burden for extended visits. If your EMR or billing system treats both groups identically, fix that workflow now. |
| 4 | Confirm homebound status is current and documented for all active cases. Home health heparin billing requires the patient to meet Medicare's homebound criteria. This is a separate requirement from NCD 210's specific criteria. Stale homebound documentation is a top audit trigger for home health reimbursement claims. |
| 5 | Check with your MAC for any local coverage determination that supplements NCD 210. This NCD sets the floor, not the ceiling. Your Medicare Administrative Contractor may have issued an LCD with additional documentation requirements, visit limits, or prior authorization triggers for home health skilled nursing visits. Don't assume the NCD is the only policy in play. |
| 6 | Document teaching visit necessity individually. NCD 210 covers "several visits" for injection teaching — but that's vague. Each teaching visit needs its own clinical justification in the record. Document what was taught, whether the patient or caring person demonstrated the skill, and why an additional visit was needed. This is your defense if an auditor questions visit count. |
| 7 | If you're billing for extended courses beyond six months for non-pregnant patients, get the physician documentation before the claim goes out. Don't bill and hope the documentation follows. The physician's written justification for extended treatment must exist before the claim is submitted. |
If your home health agency manages a high volume of anticoagulation cases, loop in your compliance officer before March 7, 2026. The line between covered and non-covered heparin billing is narrow, and the documentation requirements are specific enough that a single missing note can flip a covered visit into a denial.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Home Health Heparin Injection Visits Under NCD 210
No Specific Codes Listed in NCD 210
The NCD 210 policy document does not list specific CPT codes, HCPCS codes, or ICD-10-CM diagnosis codes. This is not unusual for an older NCD — many were written before the current coding frameworks were in place.
For home health heparin injection billing, you need to map claims to codes using:
- Your MAC's billing guidelines for skilled nursing visits under the home health prospective payment system
- The Medicare Benefit Policy Manual, Chapter 7, which NCD 210 cross-references directly — review this for claims processing instructions
- Your HHA's grouper software, which maps visit types and diagnoses to HIPPS codes under PDGM
The absence of listed codes in this policy does not reduce your documentation obligations. Medical necessity criteria, homebound status, and duration limits all apply regardless of which codes you bill.
Talk to your billing consultant or MAC representative if you're uncertain how to map heparin injection teaching visits versus daily administration visits under the current PDGM framework. The code selection matters for reimbursement — and the documentation requirements in NCD 210 must tie directly to the coded visit type.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.